A Case of Nivolumab-Induced Cutaneous Toxicity with Multiple Morphologies

A Case of Nivolumab-Induced Cutaneous Toxicity with Multiple Morphologies

Cutaneous reactions are among the most prevalent immune-related adverse events in patients treated with immunotherapy. Given that immunotherapies often act through blocking inhibitory signals on T cells, these treatments also have the potential to generate a host of immune toxicities. We report the...

Full description

Bibliographic Details
Main Authors: Emily D. Nguyen, Yun K. Xue, Melissa Danesh, Amir Ameri, Christina Q. Weng, Nikolai Klebanov, Ruth K. Foreman, Rosalynn M. Nazarian, Shadmehr Demehri, Hensin Tsao, Daniela Kroshinsky
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Dermatopathology
Subjects:
nivolumab
immune checkpoint inhibitor
cutaneous toxicity
lichenoid reaction
Online Access:https://www.karger.com/Article/FullText/505353

Internet

https://www.karger.com/Article/FullText/505353

Similar Items